Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015

FromThe Lancet Respiratory Medicine in conversation with

Start listening View podcast show

Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015

FromThe Lancet Respiratory Medicine in conversation with

ratings:

Length:

7 minutes

Released:

Aug 27, 2015

Format:

Podcast episode

Description

Håvard Skjerven and Karin Lødrup Carlsen discuss their follow-up study to the bronchiolitis ALL trial, which suggests that giving inhaled epinephrine for acute bronchiolitis in children does not confer benefit, even for those at risk of allergic disease.

Released:

Aug 27, 2015

Format:

Podcast episode

Titles in the series (100)

Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Respiratory Medicine: February 03, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: March 24, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
The Lancet Respiratory Medicine: May 15, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: March 05, 2013 by The Lancet Respiratory Medicine in conversation with
10 min listen
The UPBEAT study: The Lancet Respiratory Medicine: July 22, 2015 by The Lancet Respiratory Medicine in conversation with
14 min listen
The Lancet Respiratory Medicine: October 25, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
Sleep apnoea & heart failure: The Lancet Respiratory Medicine: November issue by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: October 31, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
The Lancet Respiratory Medicine: December 23, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: June 25, 2014 by The Lancet Respiratory Medicine in conversation with
11 min listen
The Lancet Respiratory Medicine: December 07, 2012 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: October 22, 2013 by The Lancet Respiratory Medicine in conversation with
15 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: August 04, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: July 19, 2013 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: April 10, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
Interleukin 5: The Lancet Respiratory Medicine: March 23, 2015 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: August 11, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: January 27, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
MDR tuberculosis: The Lancet Respiratory Medicine: March 9, 2015 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: June 04, 2013 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
11 min listen
The Lancet Respiratory Medicine: December 2, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
Geo-economic variations in ARDS: The Lancet Respiratory Medicine: June 14, 2017 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: April 07, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: December 17, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: August 20, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
GOLD 2007 and GOLD 2011: The Lancet Respiratory Medicine: May 18, 2015 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: October 09, 2014 by The Lancet Respiratory Medicine in conversation with
11 min listen

More Episodes from The Lancet Respiratory Medicine in conversation with

Skip carousel

Eric Lim on treatments for pleural mesothelioma by The Lancet Respiratory Medicine in conversation with
6 min listen
Anne Chang on the burden of chronic respiratory diseases in Indigenous people by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID by The Lancet Respiratory Medicine in conversation with
8 min listen
Sarah Gorst and Tim Nicholson on long COVID outcomes by The Lancet Respiratory Medicine in conversation with
16 min listen
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Keith Chappell on a bivalent recombinant vaccine for COVID-19 by The Lancet Respiratory Medicine in conversation with
8 min listen
James Chalmers on bronchiectasis across Europe by The Lancet Respiratory Medicine in conversation with
12 min listen
Richard Costello on management of uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
12 min listen
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer by The Lancet Respiratory Medicine in conversation with
6 min listen
Carol Hodgson on post-discharge outcomes for ECMO patients by The Lancet Respiratory Medicine in conversation with
19 min listen
Emma Grainger on 10 years of The Lancet Respiratory Medicine by The Lancet Respiratory Medicine in conversation with
13 min listen
Vivienne Kahlmann and Catharina Moor on the TIRED study by The Lancet Respiratory Medicine in conversation with
9 min listen
Yves Lacasse on long-term oxygen therapy for COPD by The Lancet Respiratory Medicine in conversation with
17 min listen
Rachael Evans on living with long COVID by The Lancet Respiratory Medicine in conversation with
13 min listen
Daniel Munblit and Dale Needham on core outcomes post-COVID-19 by The Lancet Respiratory Medicine in conversation with
17 min listen
Daiana Stolz on antibiotic stewardship in pneumonia by The Lancet Respiratory Medicine in conversation with
10 min listen
Ablo Wachinou on sleep disordered breathing in Benin by The Lancet Respiratory Medicine in conversation with
11 min listen
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID by The Lancet Respiratory Medicine in conversation with
15 min listen
Dinh Bui on preterm birth and lung function deficits by The Lancet Respiratory Medicine in conversation with
6 min listen
Ruvim Izĭckson on a joint flu and COVID-19 vaccine by The Lancet Respiratory Medicine in conversation with
9 min listen
Wisia Wedzicha on a vaccine for COPD by The Lancet Respiratory Medicine in conversation with
9 min listen
Eileen Rubin on patient-centered ARDS by The Lancet Respiratory Medicine in conversation with
17 min listen
Daniel Altmann on COVID boosters by The Lancet Respiratory Medicine in conversation with
16 min listen
Michael Kreuter on interstitial lung disease by The Lancet Respiratory Medicine in conversation with
8 min listen
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Charles Sprung and authors on end-of-life practices in ICUs globally by The Lancet Respiratory Medicine in conversation with
16 min listen
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
13 min listen
Paul Verweij on COVID-19 associated aspergillosis by The Lancet Respiratory Medicine in conversation with
7 min listen
Ignacio Rubio on COVID-19 pathophysiology and phenotypes by The Lancet Respiratory Medicine in conversation with
9 min listen

Related podcast episodes

Skip carousel

The Lancet Neurology: May 19, 2008 by The Lancet Neurology in conversation with
7 min listen
Beyond the myth: Unveiling the reality of penicillin allergy by The Allergist
23 min listen
Talk Evidence - Sepsis, talc and blindsided by blinding: Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM a... by Talk Evidence
41 min listen
Talk Evidence - Sepsis, talc and blindsided by blinding: Welcome to the festive ta... by The BMJ Podcast
41 min listen
Simulation-Based Planning of ALS Trials: Simulation-Based Planning of ALS Trials by Neurology Minute
2 min listen
Risk models for pregnant women with congenital heart disease: In this podcast Catherine Otto speaks to Dr P G P… by Heart podcast
10 min listen
PRINCIPLE trial findings on the use of colchicine for COVID-19 in the community by BJGP Interviews
13 min listen
Simulation-Based Planning of ALS Trials: Dr. Gordon Smith talks with Drs. Ruben P.A. van Eijk and Jordi van Unnik about the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs. Read the related article in... by Neurology® Podcast
21 min listen
The mystery of long COVID by Lab Notes
21 min listen
Penicillin Allergy – It’s Less Common Than You Think: Allergy to penicillin is one of the most commonly reported allergies by patients. In reality, true penicillin allergy is uncommon. Dr. Elizabeth Phillips from Vanderbilt University discusses her experience with testing for penicillin allergy in... by JAMA Clinical Reviews
20 min listen
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: STARDUST trial: Dr. H. Tarik Kani talks to Dr. Axel Dignass (Germany) about his recent publication about the impact of Ustekinumab on health-related quality of life in moderate-to-severe Crohn’s disease which was an open-label, multicenter, randomized study evaluated... by UEG Journal
9 min listen
Circulation September 21, 2021 Issue: Circulation Weekly: Your Weekly Summary & Backstage Pass To The Journal by Circulation on the Run
25 min listen
Neonatal survival and Lifebox: Helen Macdonald, assistant editor at the BMJ, talks to Neil Marlow, professor of neonatal medicine at University College London, about his update to the EPICure study looking at outcomes for extremely premature babies.Jane Feinmann talks to writer an... by The BMJ Podcast
30 min listen
Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19: Interview with Alex C. Spyropoulos, author of by Coronavirus (COVID-19) Q&A
17 min listen
Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19: Interview with Alex C. Spyropoulos, author of by JAMA Internal Medicine Author Interviews
17 min listen
Dosing warfarin in a postpartum woman who’s breastfeeding - Ep 136 by ACCP JOURNALS
11 min listen
Podcast 600: Penicillin Allergy?: Contributor: Aaron Lessen, MD Educational Pearls: True allergies to penicillin compared to reported allergies from patients ranges around 10% Recent study took patients undergoing sensitivity tests and developed the PEN(icillin)-FAST score to address... by Emergency Medical Minute
3 min listen
Circulation December 10, 2019 Issue: Circulation Weekly: Your Weekly Summary & Backstage Pass To The Journal by Circulation on the Run
22 min listen
Travelling when pregnant: The problems associated with arsenic in drinking water have been known for some time, but new research published in the BMJ helps quantify that risk with respect to cardiovascular disease. Yu Chen, New York University School of Medicine, joins us to ... by The BMJ Podcast
16 min listen
COVID-19 vaccination in patients with liver disease by EASL Podcasts
28 min listen
Vaccination ethics and electricity wars: Sydney Science festival news by Ian Woolf, 2015 Einstein lecturer Dr Ken Silburn talks about vaccination ethics and electricity wars, Production checked by Charles Willock, Produced and hosted by Ian Woolf Support Diffusion by making a contribution by Diffusion Science radio
20 min listen
Nailed to the naughty step by Planet Normal
60 min listen
Acute Lung Injury andamp; Acute Respiratory Distress Syndrome in dogs and cats | Dr. Deb Silverstein | VETgirl Veterinary Continuing Education Podcasts by VETgirl Veterinary Continuing Education Podcasts
21 min listen
S1E27 / Convalescent Plasma / Arturo Casadevall & Michael Busch: “With penicillin, for example, you needed a few days to begin to get better. With antibodies, these people got better within hours, almost as if the antibody was mediating an antitoxin effect.” - Arturo Casadevall In today’s episode, our host Dr. Celine Gounder speaks with Arturo Casadevall, Chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, about convalescent plasma, the transfer of antibodies from a disease survivor to a disease patient. They discuss the history of convalescent plasma transfer, how it has been used in the past during other infectious disease outbreaks, such as diphtheria and measles, and how the invention of antibiotics led to the decline of this treatment method in the United States. They also talk about the current research studies being done to test the effectiveness of this treatment method on COVID-19 patients. Our host also spe by EPIDEMIC with Dr. Celine Gounder
28 min listen
Episode 93: What the World Needs: In "What the World Needs," Dr. Osterholm discusses the new CDC guidance, provides an update on the trajectory of the pandemic nationally and internationally, discusses new data on vaccine efficacy in 5- to 11-year-olds, examines new research on the origins of SARS-CoV-2, and answers a COVID Query about Ukraine. Email us your questions: OsterholmUpdate@umn.edu Sheree's beautiful place: cidrap.umn.edu/sherees-beautiful-place by Osterholm Update
20 min listen

Discover this podcast and so much more

Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015

Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015

Description

Titles in the series (100)

More Episodes from The Lancet Respiratory Medicine in conversation with

Related podcast episodes